Stocktoria
Orchestra BioMed Holdings, Inc. OBIO
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-08-04
Orchestra BioMed Holdings, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $33.5M | $2.6M | $2.8M | $3.5M | — |
| R&D expense | $58.2M | $42.8M | $33.8M | $21.9M | — |
| SG&A expense | $26.9M | $23.9M | $20.3M | $14.0M | — |
| Operating income | -$51.8M | -$64.3M | -$51.5M | -$32.7M | -$394,756 |
| Income tax | $0 | — | — | — | — |
| Net income | -$52.7M | -$61.0M | -$49.1M | -$33.6M | -$378,753 |
| EPS (diluted) | $-1.11 | $-1.66 | $-1.48 | $-2.24 | $-0.02 |
| Operating cash flow | -$49.0M | -$50.6M | -$46.1M | -$29.3M | -$272,362 |
| Free cash flow | -$49.5M | -$50.8M | -$46.2M | -$29.9M | — |
| Cash & equivalents | $34.7M | $22.3M | $30.6M | $19.8M | $1.8M |
| Inventory | $310,000 | $173,000 | $146,000 | $276,000 | — |
| Total assets | $114.9M | $76.2M | $95.2M | $95.6M | $161.8M |
| Total liabilities | $51.5M | $43.2M | $27.2M | $43.0M | $5.8M |
| Shareholders' equity | $53.6M | $33.0M | $68.0M | $52.5M | -$19.8M |
Source: SEC EDGAR filings · CIK 0001814114 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.